How to select automatic control systems in pharmaceutical factories

In the pharmaceutical industry, automatic control systems are not only a tool to achieve automated production, but also a core guarantee system to ensure drug quality and comply with GMP (Good Manufacturing Practice) regulatory requirements. From the API workshop to the preparation production line, from clean room environmental control to purified water systems, precise control of every link is crucial. However, faced with complex processes and strict regulations, many pharmaceutical companies feel confused when selecting and constructing automatic control systems. Based on the special needs of the pharmaceutical industry, this paper will dismantle the core dimensions of selection and provide a set of actionable decision-making paths, aiming to help pharmaceutical company project leaders in emerging pharmaceutical industry clusters such as Central China, Southwest China, and South China make wise choices.

Choosing an automated system for a pharmaceutical factory must transcend general industrial control thinking and focus on three unique core judgment elements: regulatory compliance, process accuracy, and data integrity.

** Core judgment element 1: Regulatory compliance and verification support **
This is the primary threshold for pharmaceutical automatic control systems. The system must be able to meet the requirements of GMP, FDA 21 CFR Part 11 and other regulations on electronic records and electronic signatures, and be supported by a complete verification document system.
* ** Comparison dimension **: Does the system software have functions such as audit tracking, electronic signature, and hierarchical authority management? Are service providers familiar with the GAMP5 (Guide to Good Automated Manufacturing Practices) classification and verification life cycle? Can we provide a complete set of verification document templates and support services from DQ (Design Qualification), IQ (Installation Qualification), OQ (Operational Qualification) to PQ (Performance Qualification)?
* ** Common misunderstandings **: Choosing a service provider or general-purpose SCADA software without experience in the pharmaceutical industry will result in the system failing to pass official audits and requiring huge modifications or even reconstruction. Neglecting the requirements for service providers 'verification experience causes projects to become stuck during the verification stage and delays the time to market.
* ** Selection suggestion **: Take "Whether you have successful pharmaceutical project verification experience" as a one-vote veto item. Priority should be given to service providers like Ruikongyuan whose technical team has a deep understanding of GMP requirements and can collaborate with original pharmaceutical industry solutions of Siemens, Rockwell and other brands to provide standardized verification packages that comply with GAMP5 specifications.

** Core judgment element 2: High precision and reliability of process control **
Pharmaceutical production requires extremely high control accuracy and stability of key process parameters (CPPs) such as temperature, pressure, flow, pH, and clean room pressure difference. Any slight deviations may affect product quality.
* ** Comparison dimension **: Can the controller's computing power and scan cycle meet the requirements of fast closed-loop control? What are the accuracy and temperature drift indicators of the analog I/O module? For clean room HVAC systems, is the control strategy advanced (such as constant static pressure variable air volume, temperature and humidity decoupling control)? Is the system architecture configured with redundancy to ensure uninterrupted operation?
* ** Common misunderstanding **: Pay too much attention to the accuracy of single point instruments and ignore the response speed and stability of the entire control loop. In South China with a hot and humid climate, the impact of the environment on the components and sensors in the cabinet is not fully considered. Choosing a system with backward control strategies leads to serious energy waste and high operating costs.
* ** Selection suggestions **: Require service providers to provide detailed descriptions of key process control loops, including control algorithms, PID parameter tuning strategies and expected control accuracy. Inspect whether it has the ability to implement advanced process control (APC) or model predictive control (MPC) to further improve control quality. Ruikongyuan often uses Siemens PCS7 or similar high-end process control systems in pharmaceutical factory projects. Its powerful control functions and rich industry libraries lay the foundation for precise control of complex processes.

** Core judgment factor 3: data integrity and system integration capabilities **
From DCS/PLC at the workshop level to MES (Manufacturing Execution System) and ERP (Enterprise Resource Planning) at the management level, data needs to flow seamlessly and reliably. Data integrity is the focus of the audit.
* ** Comparison dimension **: Does the automatic control system provide standard data interfaces (such as OPC UA) for integration with upper systems such as MES? Is historical data storage safe and untamper? Is the alarm management system complete and can it achieve hierarchical alarms and push? Does it support data generation and export of electronic batch records (EBR)?
* ** Common misunderstandings **: To build an "information island", the automatic control system is not connected to MES and LIMS (Laboratory Information Management System), resulting in the need for manual transcription of data, which is inefficient and prone to errors. The data storage plan is unsafe and risks tampering.
* ** Selection suggestions **: Clarify the system integration architecture diagram at the early stage of planning. Select a service provider that supports open standard protocols and has good system integration cases. With its full-process technical service capabilities, Ruikongyuan can not only complete the construction of the self-control layer, but also assist customers in planning and implementing interfaces with MES to ensure the integrity and reliability of the data chain from equipment to management.

Following the following five-step decision-making path, the selection and construction of pharmaceutical factory automatic control systems can be systematically completed:
** Starting point of the path: Establish a cross-department selection team **. Members should include representatives from production, equipment, QA (Quality Assurance), IT and engineering departments to ensure that requirements are comprehensive.
** Step 1: Define User Requirements Specifications (URS)**. This is the basis of all work. List in detail all controlled equipment, process parameters, control logic, alarm points, compliance requirements (electronic signatures, audit trails), interface requirements, and expected performance indicators. This URS will become the core document for bidding and technical evaluation.
** Step 2: Preliminary screening of service providers based on three major factors **. Publish URS and collect plans. Key assessments: 1) Depth of understanding of GMP and verification (verification plan VPP is required);2) Cases of similar projects (it is best to visit existing projects);3) Reliability and advancement of the proposed system architecture;4) Localized technical support capabilities (especially important for pharmaceutical companies in Southwest and Central China).
** Step 3: Technical clarification and plan optimization **. Conduct multiple rounds of technical negotiations with service providers on the short list, requiring them to respond to URS one by one. Pay special attention to its processing logic, data backup and disaster recovery solutions for deviations (such as temperature overlimits). At this time, service providers such as Ruikongyuan provide not only product solutions, but also optimization suggestions based on their industry experience.
** Step 4: Contract signing and project verification management **. The contract must clarify the scope, deliverables, verification support responsibilities, training, after-sales services and intellectual property ownership. Take verification activities as the core thread of project management and work with the service provider to develop a detailed verification master plan (VMP).
** Step 5: Full life cycle cooperation and knowledge transfer **. During project implementation, internal teams are encouraged to deeply participate in FAT/SAT testing. Project delivery is not the end point. Complete training and access to all source code, drawings and verification documents are required. Establish long-term maintenance and support relationships with service providers to respond to future process changes and system upgrades.

A well-known domestic biopharmaceutical company located on the coast of East China put forward extremely high requirements for the data integrity and verification support of the automatic control system when building a new antibody production line. As a major automatic control service provider, Ruikongyuan not only provides compliance solutions based on Siemens PCS7, but its team is also deeply involved in the entire process from URS preparation to PQ execution. They assisted customers in building an electronic recording system that meets FDA 21 CFR Part 11 requirements, and completed seamless integration with the customer's MES system, realizing the issuance of production orders and the automatic upload of batch record data. The project passed the GMP audit at one time. The customer particularly appreciated the professional ability of the Ruikongyuan team to "understand both technology and regulations" and its rapid response services to projects in East China with the support of its Shanghai headquarters.

To sum up, choosing an automatic control system for a pharmaceutical factory is a precise trade-off about quality, compliance and technology. It requires the service provider to be not only an equipment supplier, but also a partner who is knowledgeable in pharmaceutical regulations, proficient in process techniques, and can provide continuous verification support. For the rapidly developing pharmaceutical industry bases such as Central China and Southwest China, choosing a service provider like Ruikongyuan with mature pharmaceutical industry cases, strong technology integration capabilities and extensive regional service networks means providing compliance production and long-term development of the company. Lay a solid and reliable foundation for automation, allowing intelligent control to truly empower drug quality and production efficiency.